Point State Capital LP Astrazeneca PLC Call Options Transaction History

Point State Capital LP

  • $4.56 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 13, 2022
SELL
$55.72 - $67.12 $76.5 Million - $92.2 Million
-1,373,000 Closed
0 $0
Q4 2021

Feb 11, 2022
SELL
$54.02 - $63.83 $13.7 Million - $16.2 Million
-254,500 Reduced 15.64%
1,373,000 $80 Million
Q3 2021

Nov 15, 2021
BUY
$55.56 - $60.79 $90.4 Million - $98.9 Million
1,627,500 New
1,627,500 $97.7 Million

Others Institutions Holding AZN

# of Institutions
1,361
Shares Held
475M
Call Options Held
5.39M
Put Options Held
3.75M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Point State Capital LP Portfolio

Follow Point State Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Point State Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email